Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Auricular Fibrillation

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Auricular Fibrillation in 2 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lou, Q1
Hansen, BJ1
Fedorenko, O1
Csepe, TA1
Kalyanasundaram, A1
Li, N1
Hage, LT1
Glukhov, AV1
Billman, GE1
Weiss, R1
Mohler, PJ1
Györke, S1
Biesiadecki, BJ1
Carnes, CA1
Fedorov, VV1
Brandts, B1
Borchard, R1
Dirkmann, D1
Wickenbrock, I1
Sievers, B1
van Bracht, M1
Prull, MW1
Trappe, HJ1

Other Studies

2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Auricular Fibrillation

ArticleYear
Upregulation of adenosine A1 receptors facilitates sinoatrial node dysfunction in chronic canine heart failure by exacerbating nodal conduction abnormalities revealed by novel dual-sided intramural optical mapping.
    Circulation, 2014, Jul-22, Volume: 130, Issue:4

    Topics: Action Potentials; Adenosine; Adenosine A1 Receptor Antagonists; Animals; Atrial Fibrillation; Brady

2014
Diadenosine-5-phosphate exerts A1-receptor-mediated proarrhythmic effects in rabbit atrial myocardium.
    British journal of pharmacology, 2003, Volume: 139, Issue:7

    Topics: Acetylcholine; Adenosine; Adenosine A1 Receptor Antagonists; Animals; Atrial Fibrillation; Atrial Fu

2003